Comienza en La Habana estudio clínico con vacuna antineumocócica Quimi-Vio para niños con enfermedades crónicas

Clinical study begins in Havana with Quimi-Vio pneumococcal vaccine for chronically ill kids

The Finlay Vaccine Institute (IFV) announced the start of a clinical study with Quimi-Vio, its vaccine candidate for the prevention of pneumonia, meningitis, otitis and sepsis caused by Streptococcus pneumoniae …

Clinical study begins in Havana with Quimi-Vio pneumococcal vaccine for chronically ill kids Read More